GLUE
GLUE
US61225M1027
Monte Rosa Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
878.73M EUR
2.06B EUR
1.39B EUR
1.03B EUR
Enterprise Value
295.61M EUR
2.01B EUR
1.27B EUR
937.03M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-5.29x
--
--
--
Price to Sales
30.59x
71.8x
32.29x
26.53x
Price to Book
1.8x
4.23x
2.66x
4.41x
EV/Revenue
10.29x
69.98x
29.48x
24.19x
EV/EBITDA
-1.7x
--
--
--
Price to FCF (P/FCF)
--
--
--
52.49x
EV/FCF
--
--
--
47.85x
FCF Yield
-8.47%
-1.56%
-1.42%
1.91%
ende